Focus on human microbiome to fight liver cirrhosis

22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensated cirrhosis), when such decompensated cirrhosis will progress to acute-on-chronic liver failure (ACLF), and a patient’s individual treatment response. Based on such biomarkers, we strive to develop novel diagnostic tools for earlier and better patient stratification and to establish personalised and effective treatment strategies.

Learn more

Meet us at ILC2022 on 24/06/2022, 12-13h GMT!

Don`t miss the opportunity to meet the team and receive important information about the project at ILC2022 at the EASL Community Hub! Read more.

More news

4th General Assembly Meeting, Mallorca

Our 4th GA meeting, taking place from 15-18 March 2022 in Mallorca has been successfully completed.

The first 1.5 days were reserved for our first MICROB-PREDICT paper-writing workshop. 35 scientists from all over Europe discussed 12 papers about ACLF and microbiome in four different places face-to-face and virtual at the same time!

The other days were dedicated to hear further updates and results from our different work packages. With 54 participants joining on-site and almost 20 participants remotely the meeting was a great success. Thank you all for taking part!

More events